YOUR BUSINESS AUTHORITY
Springfield, MO
AbbVie reached a deal to buy drug developer ImmunoGen.
The deal is valued at roughly $10 billion.
Through the deal, AbbVie would gain access to Elahere, an ImmunoGen ovarian cancer treatment.
Read more from Quartz.
Nixa Superintendent Gearl Loden weighs in on A-F grade cards.
Thanksgiving staple recalled at Costco
HBA of Greater Springfield executive officer to retire
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
Transportation officials discuss $471M Forward 44 initiative
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.
Ozarks Farm Stop remains open after car crashes into building